A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Clinical trial NCT05685173 · RECRUITING
Trial details
- NCT number
- NCT05685173
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-20
- Primary completion
- 2029-02-16
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.